Aminaftona no tratamento da epistaxe
Nasal haemorrhage or nosebleed, is the most common of haemorrhages due to the intense vasculization of the nose, the fragility of the nasal mucous membrane and its vulnerability to traumas and irritant agents. The aim of this study is to report on a reduction of episodes of nosebleed in two patients...
Main Authors: | Godoy José M. P. de, Batigália Fernando, Paiva João V. de, Mendes Ronaldo N., Oliveira Juliana D. de |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2003-01-01
|
Series: | Revista Brasileira de Hematologia e Hemoterapia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842003000100010 |
Similar Items
-
Recent insight into the prevalence, etiology, and outcome of epistaxis in a university hospital in Saudi Arabia
by: Sami E Alharethy
Published: (2019-01-01) -
The Endovascular Treatment of Epistaxis
by: Simon Nicolay, et al.
Published: (2015-12-01) -
Epistaxe Epistaxis
by: João Ferreira de Mello Júnior
Published: (2009-06-01) -
Efficacy of endovascular superselective chemoembolization with HepaSphere 50–100 μm microspheres saturated with cytostatic in stopping nosebleeds in patients with nasopharyngeal cancer
by: V. G. Voronov, et al.
Published: (2022-11-01) -
Standardised management of atraumatic epistaxis for improved outcomes in an emergency department with off-site ear, nose and throat cover - A quality improvement project
by: Eziefa Obuseh, et al.
Published: (2020-12-01)